• Nenhum resultado encontrado

Characterization of the salivary microbiome in patients with pancreatic cancer

N/A
N/A
Protected

Academic year: 2017

Share "Characterization of the salivary microbiome in patients with pancreatic cancer"

Copied!
16
0
0

Texto

Loading

Imagem

Table 1 Clinical characteristics of study sample (n = 108).
Figure 2 Mean relative abundances of particular genera in pancreatic cancer patients (P) compared to healthy (H) and other disease (O) patient groups
Figure 3 Abundance ratio of Leptotrichia to Porphyromonas between different patient cate- cate-gories
Figure 4 Correlation between Leptotrichia abundance from 16S rRNA sequences and from real-time qPCR

Referências

Documentos relacionados

Esta pesquisa baseia-se no mapeamento dos processos de negócios relacionados ao serviço de organização de eventos em uma pequena empresa atuante no ramo alimentício,

Two main objectives guided this thesis (1) the investigation of the variables of markedness, regarding syllable type, voicing and place of articulation in relation to production

1 – Levels of salivary anti-PGL-1 antibodies in 169 young contacts of leprosy patients.. (A) Median and range of salivary anti-PGL1 IgM and IgA in contacts of multibacillary

Tal consideración se aprecia con mayor relieve cuando se contemplan casos complicados o difíciles, “respecto de los cuales no se puede formular a pri- mera vista y de modo inmediato

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.. Diabetes Res

Em relação aos programas destaca-se o Investors in Excellence, cuja iniciativa é pioneira no Reino Unido e tem como objectivo fomentar a melhoria contínua das organizações de todo

results in an analysis of diabetic patients with controlled and uncontrolled blood glucose levels; they reported that decreased salivary flow was present in the

A phase III study conducted in Japan randomized 508 patients diagnosed with pancreatic or biliary tract cancer (cholangiocarcinoma 139 and 140 gallbladder cancer) sur- gically